Here's Why You Should Add RMD Stock to Your Portfolio Now

ResMed Inc.’s (RMD) growth in the first quarter of fiscal 2025 can be attributed to the robust performance of its Mask business. Its Device sales continue to drive overall revenue growth, driven by the combined availability of Airsense10 and Airsense11. The company’s investment in newer-to-market technologies within its Respiratory Care product space looks encouraging. However, the increasing debt burden on ResMed’s operations remains a concern.  In the past year, shares of this Zacks Rank #1 (Strong Buy) c ...